PMDI · Psychemedics Corp
$2.49
+0.00 (+0.00%)
At close · Jul 30
Market Cap
$15.21M
Shares
6.11M
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$2.49
Open$2.49
Day$2.49–2.49
52W$1.33–2.70
Avg vol 30d667
Short int3K · 0.1% float · 1000.0d
Short vol12%
DataJan 2020–Jul 2026
Filing10-K · Mar 24
Up next
FQ3-26 quarter ends
~Sep 30, 2026
Est
filed Mar 24, 2025
Equibles Rating
blended score · not investment adviceOverall
Neutral
SellHoldBuy
Technical
Neutral
Momentum
Very Strong
Sentiment
Neutral
Fundamentals
Fair
Quant / Vol
Moderate
Market backdrop
VIX 17.1 · elevated
Equity put/call 0.61
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
+25%
above
Price vs 50-day avg
+5%
above
RSI (14)
80
overbought
MACD trend
Negative
52-week position
85%
mid-range
Momentum
relative strength
1-month return
0%
trailing
6-month return
+50%
trailing
YTD return
+56%
this year
Relative strength
+41%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $2 › 200d $2 — 50d above 200d
Institutional flow
Flat
0% holders QoQ
Insider flow
Flat
No net insider activity over 90 days
Short interest
Flat
0.06% of float · ▬ 0.0% MoM · 1000.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr low
1 holders — near 1-yr low, contrarian setup
Squeeze score
49
elevated · 0–100
Fundamentals
Revenue growth
+2%
Y/Y
Gross margin
18%
contracting
EPS growth
−58%
Y/Y
Free cash flow
$878.0K
Balance sheet
$1.4M
net cash
Quant / Vol
risk profile
Volatility
54%
annualized · 1-yr
Max drawdown
−40%
past year
ATR
0.4%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders Neutral
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
+25%
Bullish
Price vs 50-day avg
+5%
Bullish
RSI (14)
80
Bearish
MACD trend
Negative
Bearish
52-week position
85%
Neutral
Market signals — smart money & positioning
No clear signal
Trend (MA cross)
No cross
50d $2 › 200d $2 — 50d above 200d
Institutional flow
Flat
0% holders QoQ
Insider flow
Flat
No net insider activity over 90 days
Short interest
Flat
0.06% of float · ▬ 0.0% MoM · 1000.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr low
1 holders — near 1-yr low, contrarian setup
Price context
position in its 52-week range
52-wk low $1
Now $2 · 85%
52-wk high $3
vs 200-day avg +25%
vs 50-day avg +5%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Diagnostics & Research — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
PMDI
this stock
Psychemedics Corp
|
$15.21M | +55.6% | +1.8% | — | 0.1% |
|
TMO
Thermo Fisher Scientific Inc.
|
$214.22B | -0.4% | +0.4% | 31.7 | 1.4% |
|
DHR
Danaher Corp /De/
|
$137.90B | -13.8% | +8.5% | 34.8 | 1.4% |
|
IDXX
Idexx Laboratories Inc /De
|
$44.08B | -15.8% | +10.4% | 41.1 | 2.7% |
|
IQV
Iqvia Holdings Inc.
|
$39.62B | +9.8% | +41.6% | 29.5 | 3.2% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Financials
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| PMDI | +0.0% | +0.0% | +50.0% | +0.0% | +55.6% |
| SPY | +0.5% | -0.6% | +9.5% | -0.7% | +8.8% |
| vs SPY | -0.5% | +0.6% | +40.5% | +0.7% | +46.9% |